Skip to main content

Solid State Fermentation Based Olive Pomace Using Streptomyces Strains: A Preliminary Study | Chapter 08 | Advances and Trends in Biotechnology and Genetics Vol. 2

This study represents a preliminary investigation aimed to assess the possibility to recycle and valorize olive pomace by solid state fermentation (SSF) using Streptomyces strains. The olive pomace was collected from an olive pressing factory (super press system) during the olive fruit pressing season. The study was carried out at IMBE, University Aix Marseille-France, between April 2013 and June 2013 and at LMA, University of Bejaia-Algeria in September 2013. Three Streptomyces strains designated S1M3I, S1M3II and S1M3III were cultured on solid state fermentation based olive pomace at 30°C for 10 days, and subsequently, the lignocellulolytic enzyme activities (xylanase, CMCase and laccase), the viability of the microorganisms and the pH of the resulting substrates, were determined. The fermented substrate pH values remained significantly stable (p ˂ 0.05) throughout the fermentation period for the three strains; they were fluctuated between 6.54 and 6.99. The viability of all Streptomyces strains studied, decreased significantly (p ˂ 0.05) during the first four days of incubation, to reach up 0 cfu/mL of viability and 0 U/g enzymatic activities (xylanase, CMCase and laccase activities) were recorded for the three strains. Streptomyces strains, under the experimental conditions (30°C, pH 7 and 75% of moisture), were unable to grow and produce lignocellulolytic enzymes in solid state fermentation based olive pomace due to the mycelial morphology and Streptomyces developmental cycle, no neglect, the environmental factors. These preliminary results suggest that SSF – Streptomyces system is not suitable for conversion of solid waste from olive processing industry and to produce lignocellulolytic enzymes.

Author(s) Details

Lamia Medouni-Haroune
Laboratoire de Microbiologie Appliquée, Faculté des Sciences de la Nature et de la Vie, Université de Bejaia, 06000 Bejaia, Algérie.

Farid Zaidi
Département des Sciences Alimentaires, Faculté des Sciences de la Nature et de la Vie, Université de Bejaia, 06000 Bejaia, Algérie.

Sevastianos Roussos
Equipe Eco Technologies et Bioremédiation, Faculté St Jérome, Campus Etoile, Aix Marseille Université & Université Avignon, IMBE UMR CNRS-7263/IRD-237, Case 421, 13397 Marseille Cedex 20, France.

Véronique Desseaux
Institut des Sciences Moléculaires de Marseille, Faculté des Sciences et Techniques, St Jérome, Biosciences UMR CNRS 6263. Université Paul Cézanne, 13397 Marseille Cedex 20, France.

Sonia Medouni-Adrar
Laboratoire de Biomathématiques, Biophysique, Biochimie, et Scientométrie (L3BS), Faculté des Sciences de la Nature et de la Vie, Université de Bejaia, 06000 Bejaia, Algérie.

Mouloud Kecha
Laboratoire de Microbiologie Appliquée, Faculté des Sciences de la Nature et de la Vie, Université de Bejaia, 06000 Bejaia, Algérie.

View Volume: https://doi.org/10.9734/bpi/atbg/v2

Comments

Popular posts from this blog

A Prospective Study about Safety and Efficacy of Perioperative Lidocaine Infusion | Chapter 09 | New Horizons in Medicine and Medical Research Vol. 8

 Opioids cause clinically significant side effects such as respiratory depression, immunosuppression, muscle rigidity, negative inotropism, nausea, vomiting, hyperalgesia, urine retention, postoperative ileus, and drowsiness. Perioperative opioids are a major contributor to the United States' and other countries' opioid epidemics. Non-opioid analgesics, particularly lidocaine, are becoming more common for perioperative use as a result of this. A total of 185 adult patients were randomly assigned to one of two groups: control group I (105 patients) [fentanyl group] or group ii (80 patients) [opioid-free anaesthesia group]. Lidocaine 1.5 mg/kg bolus followed by 1.5 mg/kg/h infusion intraoperatively, and 1.5-2 mg/kg/h infusion for 2-8 hours postoperatively were given to patients in both groups at anaesthetic induction. Intraoperatively, both groups received analgesic adjuvants such as diclofenac 75 mg, paracetamol 1 gm, and mgso4 30-50 mg/kg. If the mean arterial pressure (map)

A Brief Study of Middleware Technologies: Programming Applications and Management Systems | Chapter 15 | Novel Research Aspects in Mathematical and Computer Science Vol. 1

  Many platforms, services, applications, hardware, and operating systems are connected through the middleware layer. Because the middleware layer abstracts much low-level complexity and makes applications and software systems portable, it allows disparate systems to interface and function together in harmony. Middleware technologies enable software engineers to swiftly construct software systems and applications, allowing developers to focus on more important tasks. This chapter examines several types of middleware systems and discusses middleware capabilities, middleware operation, middleware's function in cloud-based systems, and the best middleware platforms to use. Middleware systems are widely utilised and can be found in practically any software system or application. Middleware programmes provide as a link between many sorts of systems and protocols. They serve as a mechanism for various systems. To successfully exchange information, it runs on a variety of operating system

Patients’ Perspective of Acute Post-operative Pain Management: A Multicentre Survey of Tertiary Hospitals in Maharashtra, India | Chapter 08 | New Horizons in Medicine and Medical Research Vol. 8

 When postoperative pain is adequately controlled, patients' satisfaction and patient-related outcomes (PROs) increase. Understanding the patients' perspective is crucial since it supports in the formulation of improvement strategies. Because wrong attitudes and assumptions might block pain alleviation, patients' attitudes and beliefs are critical. As a result, a multicenter study of patients' attitudes, beliefs, experiences, and satisfaction levels with acute postoperative pain management was done in Maharashtra's tertiary hospitals. In addition, the responses were examined to evaluate if the Acute Pain Service (APS) resulted in improved patient outcomes and satisfaction. A 13-item questionnaire adapted from previous studies was used to capture patients' experiences with postoperative pain treatment. The responses of 179 patients are included in the study. The findings revealed that 91.6 percent of patients experienced postoperative pain, with 75.5 percent